Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D31XQD
|
|||
| Drug Name |
TAK-951
|
|||
| Indication | Nausea and vomiting [ICD-11: MD90; ICD-10: R11] | Phase 2 | [1] | |
| Company |
Takeda
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04557189) A Randomized Double-Blind, Sponsor-Open, Double-Dummy, Proof of Concept Phase 2 Study to Evaluate the Efficacy and Safety of TAK-951 Versus Ondansetron in the Prophylaxis of Postoperative Nausea and Vomiting in High-Risk Subjects. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.